The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
The pandemic of COVID-19 has highlighted the intricate relationship between gut microbiome and overall health. Recent studies have shown that the Firmicutes/Bacteroidetes ratio in the gut microbiome may be linked to various diseases including COVID-19 and type 2 diabetes (T2D). Understanding the lin...
Main Authors: | Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223006820 |
Similar Items
-
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
by: Pavlo Petakh, et al.
Published: (2023-10-01) -
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
by: Pavlo Petakh, et al.
Published: (2023-02-01) -
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
by: Pavlo Petakh, et al.
Published: (2023-06-01) -
Effects of metformin on the gut microbiota: A systematic review
by: Pavlo Petakh, et al.
Published: (2023-11-01) -
Metformin Alters mRNA Expression of <i>FOXP3</i>, <i>RORC</i>, and <i>TBX21</i> and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes
by: Pavlo Petakh, et al.
Published: (2024-02-01)